Patients with other types of cancer prior to or within 1 year after the diagnosis of NSCLC (n = 278), those aged < 20 years, and those with negative or lack of EGFR mutations analysis (n = 154), were excluded from the analysis. The gene discussed is EGFR; the disease is cancer.